FDA Approves First Generic Once-Weekly Hormone Therapy Patch for Women

The U.S. Food and Drug Administration (FDA) has approved the first generic version of Climara Pro (estradiol and levonorgestrel transdermal system), a once-weekly transdermal hormone therapy patch for women with an intact uterus. This regulatory action expands treatment options for hormone therapy.